3-Methoxy-N-propyl-propionamide | 1340551-81-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-Methoxy-N-propyl-propionamide
• 英文别名: 3-methoxy-N-propylpropanamide
• CAS: 1340551-81-6
• 化学式: C₇H₁₅NO₂
• 分子量: 145.2
• InChiKey: GRRXRLWKPGEZKZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS
  申请人：Syngenta Crop Protection AG

  公开号：US20210087151A1

  公开（公告）日：2021-03-25

  The invention relates to substituted thiophenyl uracils of general formula (I) or salts (I) thereof, wherein the groups in general formula (I) are as defined in the description, and to the use thereof as herbicides, in particular for controlling weeds and/or weed grasses in crops of cultivated plants and/or as plant growth regulators for influencing the growth of crops of cultivated plants.

  该发明涉及通式（I）的取代噻吩基尿嘧啶或其盐，其中通式（I）中的基团如描述中所定义，并且将其用作除草剂，特别是用于控制农作物中的杂草和/或杂草草本植物，或作为植物生长调节剂，以影响农作物的生长。
• N-Terminal Pegylated Prolactin Receptor Molecules
  申请人：Peschke Bernd

  公开号：US20100035814A1

  公开（公告）日：2010-02-11

  The invention is concerned with N-terminally pegylated polypeptides capable of binding to the prolactin receptor. Such polypeptides may for instance be N-terminally pegylated antagonists of the prolactin receptor, such as for instance prolactin variants.

  本发明涉及能够结合催乳素受体的N-末端聚乙二醇化多肽。这样的多肽可以是催乳素受体的N-末端聚乙二醇化拮抗剂，例如催乳素变异体。
• MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
  申请人：DORONINA SVETLANA O.

  公开号：US20120034246A1

  公开（公告）日：2012-02-09

  Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF), were prepared and attached to Ligands through various linkers, including maleimidocaproyl-val-cit-PAB. The resulting ligand drug conjugates were active in vitro and in vivo.

  Auristatin肽包括MeVal-Val-Dil-Dap-Norephedrine (MMAE)和MeVal-Val-Dil-Dap-Phe (MMAF)，通过不同的连接剂，包括maleimidocaproyl-val-cit-PAB，制备并连接到配体上。所得的配体药物偶联物在体内外均具有活性。
• TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Babu Srinivasan

  公开号：US20110201593A1

  公开（公告）日：2011-08-18

  The invention provides novel compounds of formula I having the general formula: wherein R 1 , R 2 , R 3 , X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.

  本发明提供了具有以下一般式的新化合物I： 其中R1、R2、R3、X和Y如本文所述。因此，这些化合物可以在药学上可接受的组合物中提供，并用于治疗免疫或过度增生性疾病。
• COMPOUNDS, CONJUGATES AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES
  申请人：The Board of Trustees of the University of Illinois

  公开号：US20140187500A1

  公开（公告）日：2014-07-03

  The present application provides, among other things, compounds, compositions and methods for treating various diseases including cancer.

  本申请提供了用于治疗多种疾病，包括癌症的化合物、组合物和方法，除此之外还有其他内容。